Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts.

MLA

Al-Haddad, Mohammad A., et al. “Integrated Molecular Pathology Accurately Determines the Malignant Potential of Pancreatic Cysts.” Endoscopy, vol. 47, no. 2, Feb. 2015, pp. 136–42. EBSCOhost, https://doi.org/10.1055/s-0034-1390742.

APA

Al-Haddad, M. A., Kowalski, T., Siddiqui, A., Mertz, H. R., Mallat, D., Haddad, N., Malhotra, N., Sadowski, B., Lybik, M. J., Patel, S. N., Okoh, E., Rosenkranz, L., Karasik, M., Golioto, M., Linder, J., & Catalano, M. F. (2015). Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy, 47(2), 136–142. https://doi.org/10.1055/s-0034-1390742

Chicago

Al-Haddad, Mohammad A, Thomas Kowalski, Ali Siddiqui, Howard R Mertz, Damien Mallat, Nadim Haddad, Nidhi Malhotra, et al. 2015. “Integrated Molecular Pathology Accurately Determines the Malignant Potential of Pancreatic Cysts.” Endoscopy 47 (2): 136–42. doi:10.1055/s-0034-1390742.